The Bolar Provision: A safe harbour in Europe for biosimilars

Insights

Publication | 04.24.25

Aggressive FCA Enforcement In Customs Calls For Compliance Review

• Publication | 04.22.25

  Key Digital Asset Issues Require Antitrust Vigilance

• Publication | 04.21.25

  Long Trials Require In-House Counsel To Be The Lead Coordinator

• Publication | 04.13.25

  Werken met zelfstandigen/freelancers: wat te doen en wat te vermijden